Toxic Leads Charts While Awarapan 2 and Vishwanath & Sons Enter the 200 Crore Club
_1562328917.jpg)
The Indian box office continues to witness a high-stakes clash as multiple major releases battle for supremacy. While Yash-starrer Toxic maintains its stronghold at the pinnacle of the charts, long-running hits like Awarapan 2 and Vishwanath & Sons have officially breached the prestigious 200-crore milestone. Meanwhile, films like Irumudi are displaying remarkable consistency, keeping the momentum alive well into their second week.
Toxic Dominates Box Office Despite Slower-Than-Expected Pace
Leading the Tuesday box office charts is the Yash-starrer Toxic, which pulled in a net collection of ₹7.85 crore on its seventh day. This brings the film's cumulative domestic net earnings to ₹229.60 crore, with its total gross in India reaching ₹264.80 crore. On the global front, the action-packed entertainer has successfully crossed the ₹315 crore worldwide mark. Although its collections are slightly lower than initial market expectations, the film continues to dictate terms at the top of the box office leaderboard.
Awarapan 2 and Vishwanath & Sons Enter the 200 Crore Club
Entering their third week of theatrical release, both Awarapan 2 and Vishwanath & Sons have demonstrated exceptional staying power. Emraan Hashmi-starrer Awarapan 2 added ₹0.50 crore net on its 19th day from 1,279 shows, pushing its domestic net total to ₹148.90 crore and worldwide gross to an impressive ₹210.85 crore.
On the other hand, Vishwanath & Sons maintained a solid grip, earning ₹0.79 crore net on Tuesday from 1,281 shows. Backed by a strong overseas response, the film's global collections have officially crossed ₹200.59 crore, cementing its status as a major commercial success alongside Awarapan 2.
Irumudi Gains Steady Ground in Week Two
Continuing its stellar run, Irumudi is fast approaching the coveted 200-crore threshold. On its 12th day of release, the film registered a strong net collection of ₹5.90 crore in India, taking its domestic net total to ₹142.05 crore. With robust international appeal driving numbers higher, its worldwide gross has climbed to ₹186.50 crore, proving that compelling content can sustain a powerful theatrical trajectory even against high-profile competition.
_781154255_351x234.jpg)
_31399961_351x234.jpg)
_1836088832_351x234.jpg)
_2049050783_351x234.jpg)
_2102144456_351x234.jpg)
